HUTCHMED (China) Ltd

{ "date": [ "202612", "202712", "202812", "202912" ], "revenue_estimate": [ 652.55, 775.48, 866.76, 1111.54 ], "ebit_estimate": [ 28.87, 36.44, 68.96, 125.14 ], "ebitda_estimate": [ -7.03, 45.81, 51.52, 89.2 ], "net_income_estimate": [ 48.72, 69.98, 121.61, 156.95 ], "per_share_eps_estimate": [ 0.39, 0.64, 0.45, 0.9 ], "eps_nri_estimate": [ 0.37, 0.47, 0.46, 0.9 ], "dividend_estimate": [ null, null, null, null ], "book_value_per_share_estimate": [ 7.56, 8.01, 8.47, 9.87 ], "pretax_income_estimate": [ 6.37, 70.9, 132.66, 184.98 ], "operating_cash_flow_per_share_estimate": [ 1.07, 1.15, 0.98, 1.13 ], "roa_estimate": [ 1.82, 2.6, 3.73, 2.07 ], "roe_estimate": [ -1.18, 6.01, 8.72, 9.55 ], "gross_margin_estimate": [ 46.4, 49.4, 48.32, 46 ], "operating_cash_flow_estimate": [ 186.55, 201.39, 170.67, 196.5 ], "pettm_estimate": [ 28.31, 17.24, 24.38, 12.31 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "14.36", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 14.36, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 7.62, "future_roa_estimate_growth": -64.57, "future_roe_estimate_growth": -61.36, "future_gross_margin_estimate_growth": 7.4, "future_operating_cash_flow_per_share_estimate_growth": null }